UltraSight and Mayo Clinic Collaborate to Advance Next Generation Cardiac Care with AI

UltraSight and Mayo Clinic have embarked on a groundbreaking collaboration aimed at revolutionizing cardiac care through the integration of artificial intelligence (AI) into point-of-care ultrasound technology. This partnership seeks to advance the detection and diagnosis of cardiovascular disease by jointly developing algorithms to analyze and interpret cardiac ultrasound images. By leveraging Mayo Clinic’s extensive expertise and data resources, UltraSight aims to introduce innovative solutions that empower healthcare providers with enhanced diagnostic capabilities and decision support tools.

Dr. Paul Friedman, Chair of the Department of Cardiovascular Medicine at Mayo Clinic, highlighted the transformative potential of AI in point-of-care ultrasound, emphasizing its ability to streamline image acquisition and interpretation. This advancement is expected to significantly lower barriers to adoption and facilitate early diagnosis and continuous monitoring of cardiac health.

CEO Davidi Vortman of UltraSight underscored the importance of AI-enhanced point-of-care ultrasound in optimizing patient care. The UltraSight Real-time Guidance software, powered by AI, promises to empower a broader range of medical practitioners to confidently capture high-quality cardiac images, thereby enhancing clinical outcomes.

Through this collaboration, UltraSight and Mayo Clinic aim to pioneer a comprehensive solution that integrates cutting-edge AI technology with accessible and cost-effective point-of-care ultrasound devices, ultimately redefining standards in cardiac healthcare.


en_GBEnglish (UK)